A defect of amphiregulin release predicted longer survival independently of YAP expression in patients with pleural mesothelioma in the IFCT‐0701 MAPS phase 3 trial
暂无分享,去创建一个
O. Molinier | J. Mazières | G. Zalcman | E. Bergot | C. Danel | M. Antoine | V. Gounant | J. Levallet | H. Léna | C. Créveuil | F. Morin | I. Monnet | A. Langlais | L. Greillier | J. Margery | G. Levallet | F. Dubois | E. Maille | D. Moro-Sibilot | A. Sherpereel